Skip to main content
Caplight Logo









Molecular Garden

Molecular Garden

Private
BerlinHealthcare & Life Scienceshttps://www.moleculargarden.com/

Last Round

Accelerator

Jun 3, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Molecular Garden is a biotechnology company that produces plant-derived ingredients through precision plant cell cultivation in bioreactors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

synthetic biologybiomanufacturingbioactive ingredientsplant cell cultivationlab-grown ingredientscellular agriculturemetabolic engineeringbioreactor cultivationsustainable cosmeticsclean beauty ingredientsprecision fermentationbotanical extractionCPG ingredientsbioprocess control

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Molecular Garden Comparables

Compare Molecular Garden with similar companies based on industry and business-model similarity.

Molecular Garden comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Chi Botanic
84%
Ayana Bio
84%
Novella Innovative Technology
79%

Molecular Garden Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 3, 2026

Key People

Founding team and executive leadership

Alessandro De Simone

Co-Founder & Chief Scientific Officer

Founding Team

Molecular Garden Investors

Notable investors and investment history

Molecular Garden investors
InvestorRounds
MassChallenge SwitzerlandAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    Participated in the MassChallenge Switzerland accelerator program.

  • Apr 11, 2026

    Grew 300% QoQ from 1 to 4 employees.

Molecular Garden Filings

Explore SEC and related filing metadata, where available.

Molecular Garden filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Molecular Garden's valuation, stock price, and market status.

Is Molecular Garden a public or private company?

Molecular Garden is a private company.

What is the current stock price of Molecular Garden?

Molecular Garden is a private company with no public stock price. Caplight tracks Molecular Garden's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Molecular Garden worth (valuation)?

Valuation information for Molecular Garden is not publicly available.

Can I buy Molecular Garden stock?

Molecular Garden shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Molecular Garden's last funding round?

Molecular Garden's most recent funding round was Accelerator on June 3, 2026.

Who are the main investors in Molecular Garden?

Key investors in Molecular Garden include MassChallenge Switzerland.

Will Molecular Garden IPO soon?

No public IPO plans have been announced for Molecular Garden.

How can I track Molecular Garden secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Molecular Garden's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range4
Year FoundedN/A
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?